Lu et al. (Lu et al., 2020) found that DNA methylation-mediated lncRNA activation improved temozolomide resistance in glioblastoma, implying that SNHG12 could be a therapeutic target for overcoming temozolomide tolerance. The gene discussed is SNHG12; the disease is glioblastoma.